49 related articles for article (PubMed ID: 1815964)
1. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
2. The role of purine analogue combinations in the management of acute leukemias.
Frewin RJ; Johnson SA
Hematol Oncol; 2001 Dec; 19(4):151-7. PubMed ID: 11754391
[TBL] [Abstract][Full Text] [Related]
3. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.
Hassan HT; Zyada LE; Ragab MH; Rees JK
Eur J Clin Pharmacol; 1991; 41(6):531-6. PubMed ID: 1815964
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
Hassan HT; Veit A; Maurer HR
J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642
[TBL] [Abstract][Full Text] [Related]
5. Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
Hassan HT; Rees JK
Hematol Oncol; 1989; 7(6):429-40. PubMed ID: 2807181
[TBL] [Abstract][Full Text] [Related]
6. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro.
Kong XB; Fanucchi MP; Chou TC
Leuk Res; 1988; 12(10):853-9. PubMed ID: 3199844
[TBL] [Abstract][Full Text] [Related]
8. Triple combination of retinoic acid + 6-thioguanine + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
Tawhid H; Rees J
Leuk Res; 1990; 14(2):109-17. PubMed ID: 2314112
[TBL] [Abstract][Full Text] [Related]
9. N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
Langdon SP; Hickman JA; Gescher A; Stevens MF; Chubb D; Vickers LM
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):745-52. PubMed ID: 4018116
[TBL] [Abstract][Full Text] [Related]
10. Quantification of retinoic acid by gas-liquid chromatography-mass spectrometry: total versus all-trans-retinoic acid in human plasma.
Napoli JL; Pramanik BC; Williams JB; Dawson MI; Hobbs PD
J Lipid Res; 1985 Mar; 26(3):387-92. PubMed ID: 3989394
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells.
Hassan HT; Rees JK
Hematol Oncol; 1988; 6(1):39-45. PubMed ID: 3422632
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.
Young CW; Fanucchi MP; Declan Walsh T; Baltzer L; Yaldaei S; Stevens YW; Gordon C; Tong W; Rifkind RA; Marks PA
Cancer Res; 1988 Dec; 48(24 Pt 1):7304-9. PubMed ID: 3191501
[TBL] [Abstract][Full Text] [Related]
13. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
[TBL] [Abstract][Full Text] [Related]
14. High-dose retinol in children with acute myelogenous leukemia in remission.
Lie SO; Wathne KO; Petersen LB; Slørdahl SH; Norum KR
Eur J Haematol; 1988 May; 40(5):460-5. PubMed ID: 3163976
[TBL] [Abstract][Full Text] [Related]
15. Differentiation induction therapy of acute myelogenous leukaemias.
Hassan HT
Haematologia (Budap); 1988; 21(3):141-50. PubMed ID: 3053358
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
